Parkinsonism & Related Disorders
Volume 14, Issue 6 , Pages 465-470 , August 2008

Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family

  • C. Wider

      Affiliations

    • Department of Neurology, CHUV, Lausanne, Switzerland
    • Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • L. Skipper

      Affiliations

    • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • A. Solida

      Affiliations

    • Department of Neurology, CHUV, Lausanne, Switzerland
    • ,
  • L. Brown

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • M. Farrer

      Affiliations

    • Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • D. Dickson

      Affiliations

    • Department of Neuropathology, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Z.K. Wszolek

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
    • ,
  • F.J.G. Vingerhoets

      Affiliations

    • Department of Neurology, CHUV, Lausanne, Switzerland
    • Corresponding Author InformationCorresponding author. Service de Neurologie, CHUV BH 13, Rue du Bugnon, 1011 Lausanne, Switzerland. Tel.: +41 21 314 1232; fax: +41 21 314 1287.

Received 25 August 2007 ,Revised 27 October 2007 ,Accepted 7 November 2007.

References 

  1. de Rijk MC, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):10–15
  2. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997 Jun 27;276(5321):2045–2047
  3. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998 Apr 9;392(6676):605–608
  4. Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet. 1998 Mar;18(3):262–265
  5. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science. 2003 Oct 31;302(5646):841
  6. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, et al. The ubiquitin pathway in Parkinson's disease. Nature. 1998 Oct 1;395(6701):451–452
  7. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004 May 21;304(5674):1158–1160
  8. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003 Jan 10;299(5604):256–259
  9. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004 Nov 18;44(4):601–607
  10. Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LF, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet. 2006 Oct;38(10):1184–1191
  11. Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol. 2002 Nov;52(5):549–555
  12. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolf A, Shults C, et al. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am J Hum Genet. 2002 Jul;71(1):124–135
  13. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184
  14. Vingerhoets FJ, Schulzer M, Ruth TJ, Holden JE, Snow BJ. Reproducibility and discriminating ability of fluorine-18-6-fluoro-l-Dopa PET in Parkinson's disease. J Nucl Med. 1996 Mar;37(3):421–426
  15. Branger F. Une forme familiale de paralysieo agitante dans une souche des Grisons. J Genet Hum. 1956;5:261–270
  16. Otto FG. Ein Beitrag zu familiar gehauft auftretenden Fallen von Parkinsonismus. Nervenarzt. 1983;54:423–425
  17. Klein C, Pramstaller PP, Kis B, Page CC, Kann M, Leung J, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol. 2000 Jul;48(1):65–71
  18. Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, Pepivani I, et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol. 2005 Sep;58(3):411–422
  19. Baldereschi M, Di CA, Rocca WA, Vanni P, Maggi S, Perissinotto E, et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology. 2000 Nov 14;55(9):1358–1363
  20. Baba Y, Markopoulou K, Putzke J, Whaley NR, Farrer MJ, Wszolek ZK, et al. Phenotypic commonalities in familial and sporadic Parkinson disease. Arch Neurol. 2006;63:579–583
  21. Kimura H, Kurimura M, Wada M, Kawanami T, Kurita K, Suzuki Y, et al. Female preponderance of Parkinson's disease in Japan. Neuroepidemiology. 2002 Nov;21(6):292–296
  22. Josephs KA, Matsumoto JY, Ahlskog JE. Benign tremulous parkinsonism. Arch Neurol. 2006 Mar;63(3):354–357
  23. Wszolek ZK, Gwinn-Hardy K, Wszolek EK, Muenter MD, Pfeiffer RF, Rodnitzky RL, et al. Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism. Acta Neuropathol (Berl). 2002 Apr;103(4):344–350
  24. Gulcher JR, Jonsson P, Kong A, Kristjansson K, Frigge ML, Karason A, et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet. 1997 Sep;17(1):84–87
  25. Higgins JJ, Pho LT, Nee LE. A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov Disord. 1997 Nov;12(6):859–864
  26. Farrer M, Gwinn-Hardy K, Muenter M, DeVrieze FW, Crook R, Perez-Tur J, et al. A chromosome 4 p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet. 1999 Jan;8(1):81–85
  27. Romito LM, Contarino MF, Ghezzi D, Franzini A, Garavaglia B, Albanese A. High frequency stimulation of the subthalamic nucleus is efficacious in Parkin disease. J Neurol. 2005 Feb;252(2):208–211
  28. Schupbach M, Lohmann E, Anheim M, Lesage S, Czernecki V, Yaici S, et al. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Mov Disord. 2007 Jan;22(1):119–122
  29. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003 Mar;60(3):387–392
  30. Hall DA, Berry-Kravis E, Jacquemont S, Rice CD, Cogswell J, Zhang L, et al. Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology. 2005 Jul 26;65(2):299–301
  31. Winter C, Juckel G, Plotkin M, Niehaus L, Kupsch A. Paranoid schizophrenia and idiopathic Parkinson's disease do coexist: a challenge for clinicians. Psychiatry Clin Neurosci. 2006 Oct;60(5):639
  32. Lam RW. Chronic schizophrenia and idiopathic Parkinson's disease. Can J Psychiatry. 1993 Mar;38(2):75–77
  33. Vingerhoets FJ, Snow BJ, Lee CS, Schulzer M, Mak E, Calne DB. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol. 1994 Nov;36(5):759–764
  34. van de Warrenburg BP, Lammens M, Lucking CB, Denefle P, Wesseling P, Booij J, et al. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology. 2001 Feb 27;56(4):555–557
  35. Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl J, et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology. 2004 May 11;62(9):1619–1622
  36. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron. 2004 Nov 18;44(4):595–600
  37. Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR, et al. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol. 2005 May;57(5):762–765
  38. Papapetropoulos S, Singer C, Ross OA, Toft M, Johnson JL, Farrer MJ, et al. Clinical heterogeneity of the LRRK2 G2019S mutation. Arch Neurol. 2006 Sep;63(9):1242–1246
  39. Wszolek Z, Vieregge P, Uitti RJ, Gasser T, Yasuhara O, McGeer P, et al. German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia: longitudinal observations. Parkinsonism Relat Disord. 1997;3:125–139
  40. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998 Feb;18(2):106–108
  41. Golbe LI, Di IG, Bonavita V, Miller DC, Duvoisin RC. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol. 1990 Mar;27(3):276–282
  42. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46 K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004 Feb;55(2):164–173

PII: S1353-8020(07)00250-7

doi: 10.1016/j.parkreldis.2007.11.013

Parkinsonism & Related Disorders
Volume 14, Issue 6 , Pages 465-470 , August 2008

Article Tools

* Image Usage & Resolution